Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet

• Published in: Journal of lipid research 2006-12, Vol.47 (12), p.2668-2680
• Main Authors: Flowers, Matthew T, Groen, Albert K, Oler, Angie Tebon, Keller, Mark P, Choi, YounJeong, Schueler, Kathryn L, Richards, Oliver C, Lan, Hong, Miyazaki, Makoto, Kuipers, Folkert, Kendziorski, Christina M, Ntambi, James M, Attie, Alan D
• Format: Article
• Language: English
• Subjects: Animals; Cholestasis - blood; Cholestasis - etiology; Cholestasis - metabolism; Cholestasis - prevention & control; Diet, Fat-Restricted - adverse effects; Dietary Carbohydrates - administration & dosage; Dietary Fats, Unsaturated - administration & dosage; Female; Hypercholesterolemia - blood; Hypercholesterolemia - etiology; Hypercholesterolemia - metabolism; Hypercholesterolemia - prevention & control; Lipid Metabolism; Lipids - blood; Lipoproteins, LDL - blood; Lipoproteins, LDL - metabolism; Liver - metabolism; Liver Glycogen - metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Stearoyl-CoA Desaturase - deficiency; Stearoyl-CoA Desaturase - genetics; Triglycerides - blood; Triglycerides - metabolism
• ISSN: 0022-2275; 1539-7262
• DOI: 10.1194/jlr.M600203-JLR200

Stearoyl-coenzyme A desaturase 1-deficient (SCD1⁻/⁻) mice have impaired MUFA synthesis. When maintained on a very low-fat (VLF) diet, SCD1⁻/⁻ mice developed severe hypercholesterolemia, characterized by an increase in apolipoprotein B (apoB)-containing lipoproteins and the appearance of lipoprotein X. The rate of LDL clearance was decreased in VLF SCD1⁻/⁻ mice relative to VLF SCD1⁺/⁺ mice, indicating that reduced apoB-containing lipoprotein clearance contributed to the hypercholesterolemia. Additionally, HDL-cholesterol was dramatically reduced in these mice. The presence of increased plasma bile acids, bilirubin, and aminotransferases in the VLF SCD1⁻/⁻ mice is indicative of cholestasis. Supplementation of the VLF diet with MUFA- and PUFA-rich canola oil, but not saturated fat-rich hydrogenated coconut oil, prevented these plasma phenotypes. However, dietary oleate was not as effective as canola oil in reducing LDL-cholesterol, signifying a role for dietary PUFA deficiency in the development of this phenotype. These results indicate that the lack of SCD1 results in an increased requirement for dietary unsaturated fat to compensate for impaired MUFA synthesis and to prevent hypercholesterolemia and hepatic dysfunction. Therefore, endogenous MUFA synthesis is essential during dietary unsaturated fat insufficiency and influences the dietary requirement of PUFA.